Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy

European Journal of Pharmacology

Volumn 596, Issue 1-3, 2008, Pages 77-83

  Arora, Manish ^a   Kumar, Ashutosh ^a   Kaundal, Ravinder K ^a   Sharma, Shyam S ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Allodynia; Diabetic neuropathy; Motor nerve conduction velocity; Nerve blood flow; Nociception; Oxidative stress; PARP; Peroxynitrite; Streptozotocin

Indexed keywords

GLUTATHIONE; NEUROPROTECTIVE AGENT; PEROXYNITRITE; TETRAKIS (4 SULFONATOPHENYL) PORPHYRINATO IRON; TETRAKIS (METHYL 4 PYRIDYL) PORPHYRINATO IRON; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CATALYST; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; HYPERALGESIA; MALE; MOTOR NERVE CONDUCTION; NERVE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TREATMENT RESPONSE;

ANIMALS; BLOOD GLUCOSE; CATALYSIS; DIABETIC NEUROPATHIES; GLUTATHIONE; MALE; METALLOPORPHYRINS; NEURAL CONDUCTION; PEROXYNITROUS ACID; POLY ADENOSINE DIPHOSPHATE RIBOSE; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SCIATIC NERVE; TYROSINE;

EID: 53249085786     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.08.003     Document Type: Article

References (38)

1. Bartosz G. Peroxynitrite: mediator of the toxic action of nitric oxide. Acta Biochim. Pol. 43 (1996) 645-659
2. Cameron N.E., and Cotter M.A. Effects of chronic treatment with a nitric oxide donor on nerve conduction abnormalities and endoneurial blood flow in streptozotocin-diabetic rats. Eur. J. Clin. Investig. 25 (1995) 19-24
3. Coppey L.J., Gellett J.S., Davidson E.P., Dunlap J.A., and Yorek M.A. Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats. Diabetes/Metab. Res. Rev. 18 (2002) 49-56
4. Cuzzocrea S., Mazzon E., Di Paola R., Esposito E., Macarthur H., Matuschak G.M., and Salvemini D. A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock. J. Pharmacol. Exp. Ther. 319 (2006) 73-81
5. Drel V.R., Pacher P., Vareniuk I., Pavlov I., Ilnytska O., Lyzogubov V.V., Tibrewala J., Groves J.T., and Obrosova I.G. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice. Eur. J. Pharmacol. 569 (2007) 48-58
6. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23 (2002) 599-622
7. Freshwater J.D., Svensson C.I., Malmberg A.B., and Calcutt N.A. Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes 51 (2002) 2249-2255
8. Fujimoto Y., Uno E., and Sakuma S. Effects of reactive oxygen and nitrogen species on cyclooxygenase-1 and -2 activities. Prostaglandins Leukot. Essent. Fat. Acids 71 (2004) 335-340
9. Kiss L., and Szabo C. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity. Mem. Inst. Oswaldo Cruz 100 Suppl 1 (2005) 29-37
10. Kooy N.W., Royall J.A., Ischiropoulos H., and Beckman J.S. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic. Biol. Med. 16 (1994) 149-156
11. Kumar A., Kaundal R.K., Iyer S., and Sharma S.S. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci. 80 (2007) 1236-1244
12. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
13. Mabley J.G., Liaudet L., Pacher P., Southan G.J., Groves J.T., Salzman A.L., and Szabo C. Part II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis. Mol. Med. 8 (2002) 581-590
14. Marla S.S., Lee J., and Groves J.T. Peroxynitrite rapidly permeates phospholipid membranes. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 14243-14248
15. Misko T.P., Highkin M.K., Veenhuizen A.W., Manning P.T., Stern M.K., Currie M.G., and Salvemini D. Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J. Biol. Chem. 273 (1998) 15646-15653
16. Moron M.S., Depierre J.W., and Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim. Biophys. Acta 582 (1979) 67-78
17. Nedelec E., Abid A., Cipolletta C., Presle N., Terlain B., Netter P., and Jouzeau J. Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism. Biochem. Pharmacol. 61 (2001) 965-978
18. Obrosova I.G., Drel V.R., Pacher P., Ilnytska O., Wang Z.Q., Stevens M.J., and Yorek M.A. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 54 (2005) 3435-3441
19. Obrosova I.G., Mabley J.G., Zsengeller Z., Charniauskaya T., Abatan O.I., Groves J.T., and Szabo C. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB. J. 19 (2005) 401-403
20. Obrosova I.G., Drel V.R., Oltman C.L., Mashtalir N., Tibrewala J., Groves J.T., and Yorek M.A. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am. J. Physiol., Endocrinol. Metab. 293 (2007) E1645-1655
21. Pacher P., and Szabo C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr. Opin. Pharmacol. 6 (2006) 136-141
22. Patel R.P., McAndrew J., Sellak H., White C.R., Jo H., Freeman B.A., and Darley-Usmar V.M. Biological aspects of reactive nitrogen species. Biochim. Biophys. Acta 1411 (1999) 385-400
23. Pop-Busui R., Marinescu V., Van Huysen C., Li F., Sullivan K., Greene D.A., Larkin D., and Stevens M.J. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-l-carnitine administration. Diabetes 51 (2002) 2619-2628
24. Rundquist I., Smith Q.R., Michel M.E., Ask P., Oberg P.A., and Rapoport S.I. Sciatic nerve blood flow measured by laser Doppler flowmetry and [14C]iodoantipyrine. Am. J. Physiol. 248 (1985) H311-317
25. Salvemini D., Wang Z.Q., Stern M.K., Currie M.G., and Misko T.P. Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2659-2663
26. Sayyed S.G., Kumar A., and Sharma S.S. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy. Life Sci. 79 (2006) 777-783
27. Sharma S.S., Munusamy S., Thiyagarajan M., and Kaul C.L. Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal cerebral ischemia. J. Neurosurg. 101 (2004) 669-675
28. Sharma S.S., Kumar A., and Kaundal R.K. Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy. Life Sci. 82 (2008) 570-576
29. Sima A.A. Pathological mechanisms involved in diabetic neuropathy: can we slow the process?. Curr. Opin. Investig. Drugs 7 (2006) 324-337
30. Stamler J.S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78 (1994) 931-936
31. Stevens M.J., Obrosova I., Cao X., Van Huysen C., and Greene D.A. Effects of dl-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49 (2000) 1006-1015
32. Sweitzer S.M., Medicherla S., Almirez R., Dugar S., Chakravarty S., Shumilla J.A., Yeomans D.C., and Protter A.A. Antinociceptive action of a p38alpha MAPK inhibitor, SD-282, in a diabetic neuropathy model. Pain 109 (2004) 409-419
33. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol. Lett. 140-141 (2003) 105-112
34. Szabo C. Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacol. Res. 52 (2005) 60-71
35. Szabo C., Salzman A.L., and Ischiropoulos D. Peroxynitrite-mediated oxidation of dihydrorhodamine123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett. 372 (1995) 229-232
36. Takeuchi M., and Low P.A. Dynamic peripheral nerve metabolic and vascular responses to exsanguination. Am. J. Physiol. 253 (1987) E349-353
37. Thiyagarajan M., Kaul C.L., and Sharma S.S. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats. Br. J. Pharmacol. 142 (2004) 899-911
38. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27 (1969) 502-522